Remedy for corneal failure
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SENJU PHARMA CO LTD
- Publication Date
- 2008-08-27
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a corneal nerve axon extension promoter comprising a somatostatin receptor antagonist, and a corneal nerve axon-based extension for restoring or improving corneal sensitivity or treating dry eye or corneal Agents for epithelial defects. Background technique
[0002] Since the corneal nerve is severed by corneal surgical procedures such as laser photorefractive keratotomy (PRK), laser-assisted in situ keratectomy (LASIK), keratoplasty, etc., corneal sensitivity is said to usually decrease for about 3 weeks to 1 year. As a result of reduced function of corneal sensitivity, patients blink less frequently after corneal surgery, problematically exhibiting symptoms of dry eye. In dry eye patients, lacrimal hypofunction produces corneal hyposensitivity, which, in combination with additional lacrimal hypofunction, may exacerbate corneal surface disorders. However, currently restoration of corneal sensitivity after corneal sur...